February 4, 2010

ApoCell Awarded Contract to Develop Circulating Tumor Cell Isolation Technology (ApoStream^TM) from NCI's Division of Cancer Treatment and Diagnosis (DCTD)

June 1, 2011, Houston

ApoCell Launches Revolutionary Circulating Cancer Cell Detection System - ApoStream^TM

August 10, 2011, Houston

ApoCell Awarded $2.9M from SAIC-Frederick, Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells

August 24, 2011, Houston

ApoCell named to Inc Magazine's List of the 5000 Fastest Growing Private Companies

September 23, 2011, Houston

ApoCell named to Houston Business Journal's List of the 100 Fastest-Growing Private Companies in Houston

September 30, 2011, Houston

ApoCell awarded SBIR Grant to Develop Point of Care Device for Antibody Independent Isolation of Circulating Tumor Cells